In addition to being a talented teacher, surgeon, and humanitarian, John Karickhoff, MD'64, HS‘64-'68, is a visionary. He recently gave $1 million to launch the Duke Ocular Innovation Hub. The hub will serve both as an engine to drive innovation and a repository for innovations developed at Duke Eye Center.  

Among the risks posed by a rapidly changing climate is the threat of fungal pathogens. Fungal infections currently cause 1.5 million deaths worldwide, and rising temperatures have the potential to make pathogenic fungi still more dangerous.

Duke Health’s Collaborative to Advance Clinical Health Equity (CACHE) is a community-driven initiative that leverages the power of data science to identify and eliminate health care disparities.

The OR Black Box system records virtually everything that happens from beginning to end during surgical procedures— all in the interest of making sure every patient at Duke has the safest and most positive possible outcome.

Duke Health is one of the nation’s leading transplant centers; we perform over 400 life-saving congenital heart surgeries annually, with shorter wait times and better survival rates for heart transplants than the national average. In recent years, Duke’s heart surgeons have pioneered a series of breakthrough heart transplant procedures, giving new life and new hope to children and adults who would otherwise have had no options.

Few challenges in medicine are more daunting, or more important, than Alzheimer’s disease. That’s exactly why we have embraced this challenge, and why we will not rest until we succeed.

UNC Health and Duke Health are uniting to create a new children’s health system in North Carolina, featuring the state’s first freestanding hospital dedicated to caring for kids.

Last year, Duke became the first institution in North Carolina to offer lecanemab, the first drug targeting the underlying processes of Alzheimer’s disease that has shown a clinical benefit. Duke now conducts the largest lecanemab clinic in the state, giving early-stage Alzheimer’s patients the gift of time and raising awareness about the need for more research.

Researchers at the Duke Human Vaccine Institute successfully created an HIV vaccine candidate that guides key immune cells along an evolutionary pathway to become broadly neutralizing antibodies.

Patients with ductal carcinoma in situ (DCIS) are usually treated with surgery and radiation, even though it may not develop into invasive breast cancer. Dr. Shelley Hwang recently presented a study suggesting that active monitoring could be an equally effective and less aggressive option for many women.